Efficacy of sublingual specific immunotherapy in patients with respiratory allergy to Alternaria alternata: a randomised, assessor-blinded, patient-reported outcome, controlled 3-year trial

References

• Holt PG, Macaubas C, Stumbles PA, et al. The role of allergy in the development of asthma. Nature 1999;402:B12-17
   PubMed Web of Science ®Google Scholar
• Denning DW, O'Driscoll BR, Hogaboam CM, et al. The link between fungi and severe asthma: a summary of the evidence. Eur Respir J 2006;27:615-26
   PubMed Web of Science ®Google Scholar
• Bush RK, Prochnau JJ. Alternaria-induced asthma. J Allergy Clin Immunol 2004;113:227-34
   PubMed Web of Science ®Google Scholar
• Wilson DR, Lima MT, Durham SR. Sublingual immunotherapy for allergic rhinitis: systemic review and meta-analysis. Allergy 2005;60:4-12
   PubMed Web of Science ®Google Scholar
• Canonica GW, Bousquet J, Casale T, et al. Sub-lingual immunotherapy: a World Allergy Association Position Paper 2009; Allergy 2009;64(Suppl 91):1-59
   PubMed Web of Science ®Google Scholar
• ARIA Allergic rhinitis and its impact on asthma. ARIA workshop report. J Allergy Clin Immunol 2001;108(5 Suppl):1-205
   Google Scholar
• Masoli M, Fabian D, Holt S, et al. The global burden of asthma: executive summary of the GINA Dissemination Committee Report. Allergy 2004;59:469-78
   PubMed Web of Science ®Google Scholar
• Braido F, Bousquet PJ, Brzoza Z, et al. Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA(2)LEN taskforce position paper. Allergy 2010;65:959-68
   PubMed Web of Science ®Google Scholar
• O'Driscoll BR, Powell G, Chew F, et al. Comparison of skin prick tests with specific serum immunoglobulin E in the diagnosis of fungal sensitization in patients with severe asthma. Clin Exp Allergy 2009;39:1677-83
   PubMed Web of Science ®Google Scholar
• Portnoy JM. Importance of mold allergy in asthma. Curr Allergy Asthma Rep 2008;8:71-8
   PubMed Web of Science ®Google Scholar
• Hamilos DL. Allergic fungal rhinitis and rhinosinusitis. Proc Am Thorac Soc 2010;7:245-52
   PubMedGoogle Scholar
• Mari A, Schneider P, Wally V, et al. Sensitization to fungi: epidemiology, comparative skin tests, and IgE reactivity of fungal extracts. Clin Exp Allergy 2003;33:1429-38
   PubMed Web of Science ®Google Scholar
• Randriamanantany ZA. Alternaria sensitization and allergic rhinitis with or without asthma in the French Six Cities study. Allergy 2010;65: 368-75
   PubMed Web of Science ®Google Scholar
• O’Hollaren MT. Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. N Engl J Med 1991;324:359-63
   PubMed Web of Science ®Google Scholar
• Bartra J, Belmonte J, Torres-Rodriguez JM, et al. Sensitization to Alternaria in patients with respiratory allergy. Front Biosci 2009;14:3372-9
   Web of Science ®Google Scholar
• Pulimood TB, Corden JM, Bryden C, et al. Epidemic asthma and the role of the fungal mold Alternaria alternata. J Allergy Clin Immunol 2007;120:610-17
   PubMed Web of Science ®Google Scholar
• Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998;102:558-62
   PubMed Web of Science ®Google Scholar
• Di Rienzo V, Marcucci F, Puccinelli P, et al. Long-lasting effect of sublingual immunotherapyin children with asthma due to house dust mite: a 10-year prospective study. Clin Exp Allergy 2003;33:206-10
   PubMed Web of Science ®Google Scholar
• Pajno GB, Caminiti L, Vita D, et al. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study. J Allergy Clin Immunol 2007;120:164-70
   PubMed Web of Science ®Google Scholar
• Penagos M, Compalati E, Tarantini F, et al. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. Ann Allergy Asthma Immunol 2006;97:141-8
   PubMed Web of Science ®Google Scholar
• Milani M, Pecora S, Burastero S; EFESO Investigators Study Group. Observational study of sublingual specific immunotherapy in persistent and intermittent allergic rhinitis: the EFESO trial. Curr Med Res Opin 2008;24:2719-24
   PubMed Web of Science ®Google Scholar
• Acquistapace F, Agostinis F, Castella V, et al. Efficacy of sublingual specific immunotherapy in intermittent and persistent allergic rhinitis in children: an observational case-control study on 171 patients. The EFESO-children multicenter trial. Pediatr Allergy Immunol 2009;20:660-4
   PubMed Web of Science ®Google Scholar
• Horst M, Hejjaoui A, Horst V, et al. Double-blind, placebo controlled rush immunotherapy with standardized Alternaria extract. J Allergy Clin Immunol 1990;85:460-72
   PubMed Web of Science ®Google Scholar
• Olaguibel JM, Alvarez Puebla MJ. Efficacy of sublingual allergen vaccination for respiratory allergy in children. Conclusions from one meta-analysis. J Invest Allergol Clin Immunol 2005;15:9-16
   PubMed Web of Science ®Google Scholar
• Molina C. Immunotherapy with an oral Alternaria extract in childhood asthma. Clinical safety and efficacy and effects on in vivo and in vitro parameters. Allergol Immunopathol (Madr) 2002;30:319-30
   PubMedGoogle Scholar
• Patrick DL, Burke LB, Powers JH, et al. Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health 2007;10(Suppl 2):S125-37
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services FDA Center for Drug Evaluation and Research. Guidance for Industry: patient reported outcome measures: use in medical product development to support labelling claims: draft guidance. Health Qual Life Outcomes 2006;4:79
   PubMed Web of Science ®Google Scholar